Mature oocyte yield in patients with diminished ovarian reserve treated with luteal estradiol priming with or without GnRH antagonist

Minerva Obstetrics and Gynecology 2026

View at publisher
Authors: Atoosa Ghofranian, Morgan Baird, Jensen D. Reckhow, Amalia G. Namath, Allison Eubanks, Anupama Rambhatla, Joseph A. Lee, Phillip A. Romanski, Alan B. COPPERMAN, Eric D. Flisser, Kerry S. FLANNAGAN
DOI: 10.23736/s2724-606x.26.05836-7
Cited by: 1
References: 26

Abstract

BACKGROUND: Luteal phase E2 priming is commonly used in patients with DOR to 30 synchronize follicular development before controlled ovarian hyperstimulation (COH). Some protocols 31 incorporate a GnRH antagonist during the luteal phase to further suppress endogenous gonadotropins, 32 though data on its added benefit are limited. METHODS: This retrospective cohort study analyzed 1555 IVF cycles from 1212 patients with AMH

Fields of Study & Subjects

Ovarian function and disorders Reproductive Biology and Fertility Ovarian cancer diagnosis and treatment

Publication details

Journal / source
Minerva Obstetrics and Gynecology
Publisher
Edizioni Minerva Medica
Volume
78
Issue
4
Pages
323–330
Publication date
17 April 2026
Language
EN